Fan, J., Zhou, J., Huang, X., Gao, Q., Shi, J., Cheng, X., Wang, W., Wei, S., Gu, L., Zheng, L., Gu, S., Hao, C., Wu, J., Zhao, Z., Xu, R., Zhang, Q., Li, B., Tang, Y., Ding, X., Yu, Z. (2026). Objective response rates with Ori-C101, an armored GPC3-directed CAR-T, in heavily pretreated advanced HCC: Updated results from the phase Ib BEACON study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.2508